News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Al-Ola A Abdallah: Will we soon see Belantamab back in relapse myeloma as part of a combination therapy?
Al-Ola A Abdallah and Vania Hungria
Oct 26, 2024, 12:33

Al-Ola A Abdallah: Will we soon see Belantamab back in relapse myeloma as part of a combination therapy?

Al-Ola A Abdallah, Associate Professor, Plasma Cell disorder program Director, Division of HMCT at University of Kansas Medical Center, shared an article by Vania Hungria, Department of hematology at Santa Casa de São Paulo, on X:

” Will we soon see Belantamab back in relapse myeloma as part of a combination therapy?”

Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma

Authors: Vania Hungria, Pawel Robak, Marek Hus, Vera Zherebtsova, Christopher Ward, P. Joy Ho, D.Phil and Ana Carolina Ribas de Almeida

Al-Ola A Abdallah

Al-Ola A Abdallah

Al-Ola A Abdallah Ana Carolina Ribas de Almeida cancer Christopher Ward combination therapy D.Phil Marek Hus Myeloma OncoDaily Oncology P. Joy Ho Pawel Robak Santa Casa de São Paulo University of Kansas Medical Center Vania Hungria Vera Zherebtsova
Special Coverage
Insight
Oct 26, 2024, 18:39
Groundbreaking EMBER-4 Clinical Trial for Early Breast Cancer
Blog
Oct 26, 2024, 18:34
Zainab Shinkafi-Bagudu: Honored to be a panelist in The White House on the invitation of Biden Cancer moon shot
Blog
Oct 26, 2024, 18:30
MD Anderson's Boot Walk to End Cancer on Nov 2
Insight
Oct 26, 2024, 18:28
SAGA Trial Achieves Full Recruitment: A Milestone in Cancer Research
Blog
Oct 26, 2024, 18:22
Naveen Pemmaraju: Honored to speak and moderate two key sessions at the 16th International MPN Congress
Insight
Oct 26, 2024, 18:16
Key Insights from APCLC webinar - Lung Cancer Policy Network
Blog
Oct 26, 2024, 18:14
Abstract submission or the AACR IO Conference on Discovery and Innovation in Cancer Immunology
Blog
Oct 26, 2024, 18:14
BeiGene's BTK Inhibitor was successfully launched in Ethiopia for CLL patients at Black Lion Hospital
Blog
Oct 26, 2024, 18:07
CPOEM Foundation's Webinar on Molecular Understanding and Treatment Landscape of Gliomas
Insight
Oct 26, 2024, 18:03
Predicting treatment efficacy among cancer patients via ‘digital twins’
Blog
Oct 26, 2024, 17:39
Christian Rolfo: Putalyo Calvo on overcoming PD-1/PD-L1 immunotherapy limitations
Blog
Oct 26, 2024, 17:36
Highlights from the 2024 Childhood Cancer International Annual International Conference in Honolulu